These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 27387826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A Polysaccharide Purified From Ganoderma lucidum Acts as a Potent Mucosal Adjuvant That Promotes Protective Immunity Against the Lethal Challenge With Enterovirus A71.
    Lin YL, Shih C, Cheng PY, Chin CL, Liou AT, Lee PY, Chiang BL.
    Front Immunol; 2020; 11():561758. PubMed ID: 33117346
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
    Huang SW, Huang YH, Tsai HP, Kuo PH, Wang SM, Liu CC, Wang JR.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931688
    [Abstract] [Full Text] [Related]

  • 12. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q, Wang Y, Bian L, Xu M, Liang Z.
    Emerg Microbes Infect; 2016 Jul 20; 5(7):e75. PubMed ID: 27436364
    [Abstract] [Full Text] [Related]

  • 13. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
    Hsieh W-S, Chao C-H, Shen C-Y, Cheng D, Huang S-W, Wang Y-F, Chen C-C, Chen S-H, Hsu L-J, Wang J-R.
    J Virol; 2024 Jan 23; 98(1):e0155823. PubMed ID: 38174926
    [Abstract] [Full Text] [Related]

  • 14. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
    Meng T, Wong SM, Chua KB.
    J Virol; 2021 Oct 27; 95(22):e0105521. PubMed ID: 34468173
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution.
    Huang SW, Tai CH, Fonville JM, Lin CH, Wang SM, Liu CC, Su IJ, Smith DJ, Wang JR.
    J Virol; 2015 Nov 27; 89(22):11500-6. PubMed ID: 26339057
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
    Liu CC, Wu SC, Wu SR, Lin HY, Guo MS, Yung-Chih Hu A, Chow YH, Chiang JR, Shieh DB, Chong P.
    Vaccine; 2018 May 24; 36(22):3134-3139. PubMed ID: 28274636
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.